Selection of blockbuster announcements

1、$Golly Pharmaceuticals-B (01672.HK) $3CLpro inhibitor ASC11 is expected to be an effective drug in the treatment of COVID-19.

Golly Pharmaceutical-B announced that its oral small molecule drug candidate ASC11 (3CLpro inhibitor) is expected to become an effective drug for the treatment of COVID-19. It is reported that ASC11 is an oral small molecule drug candidate developed independently using proprietary technologies including molecular simulation docking and targeting 3CLpro, and has global intellectual property rights.

2、$Yitai Coal (03948.HK) $The gross profit of sales in the first quarter was 5.475 billion yuan, an increase of 117.09% over the same period last year.

Yitai Coal announced that in the first quarter of this year, sales revenue was 12.143 billion yuan, an annual increase of 48.8%; sales cost was 6.668 billion yuan, an increase of 18.2%; and sales gross profit was 5.475 billion yuan, an increase of 117.1%. During the quarter, coal production was 12.3967 million tons, an annual increase of 28.9 percent, and coal sales were 17.3174 million tons, a slight increase of 0.5 percent.

3、$Chinalco International (02068.HK) $The value of newly signed contracts in the first quarter was 11.011 billion yuan, an increase of 50.32% over the same period last year.

Chinalco International announced that in the first quarter of 2022, the company signed 1583 new contracts, with a new contract value of 11.011 billion yuan, an increase of 50.32% over the same period last year.

4、$Li Ning Co. Ltd. (02331.HK) $In the first quarter, same-store sales grew at a low rate of 20%, 50% and 30% year-on-year

In terms of same-store sales, same-store sales of Li Ning Co. Ltd. (excluding Li Ning Co. Ltd. YOUNG) across the platform recorded low annual growth of 20 to 30 per cent. In terms of channels, retail (direct) channels recorded middle growth of 20% to 30%, and wholesale (franchise) channels recorded low growth of 10% to 20%. The ecommerce store business is growing at a mid-year rate of 30% to 40%.

5、$China Tower Corporation (00788.HK) $The profit attributable to shareholders in the first quarter was 2.18 billion yuan, an increase of 28.7% over the same period last year.

China Tower Corporation announced that in the first quarter of this year, operating income reached 22.633 billion yuan, an annual increase of 7 percent. EBITDA recorded 15.682 billion yuan, a slight increase of 0.8%. The EBITDA rate was 69.3%. The profit attributable to shareholders was 2.18 billion yuan, an increase of 28.7%.

• Important matters

Poly Xiexin Energy (03800) and TCL Technology plan to jointly invest 12 billion yuan to build photovoltaic and electronic grade silicon projects.

China Jinmao (00817) signs a new framework agreement with Sinochem factoring

Minmetals Resources (01208): Las Bambas will not be able to maintain copper production

China Huarong (02799) issued by Beijing Gold Institute Huarong Xiangjiang Bank equity transfer information listed at 11.9807 billion yuan.

Jinan Port Aviation Division affiliated to Hong Kong Aerospace Science and Technology (01725) and SDIISIT plan to cooperate in the construction and operation of agricultural satellite constellations

Conoya-B (02162) was awarded fast track qualification by FDA in the United States in developing a new drug, CMG901.

Sino Biopharmaceutical (01177): antineoplastic drug "Anlotinib Hydrochloride capsule" was approved for the fifth indication.

BeiGene, Ltd. (06160): the State Drug Administration approved Bai Zean ®for second-line treatment of esophageal squamous cell carcinoma.

Golly Pharmaceutical-B (01672): 3CLpro inhibitor ASC11 is expected to be an effective drug in the treatment of COVID-19

BeiGene, Ltd. (06160): updated data analysis of phase 3 clinical trials RATIONALE-309 will be announced at the ASCO meeting.

Fu Hong Hanlin (02696): the results of phase 1 clinical study of HLX20 in the treatment of advanced solid tumor showed that it was safe and well tolerated.

Clover organism-B (02197): the latest persistence and enhanced needle data of COVID-19 's candidate vaccine will be presented at the 2022 World Vaccine Congress in Washington.

• Financial report data

361degrees (01361): retail sales of main brand products achieved high double-digit growth in the first quarter compared with the same period last year.

Yitai Coal (03948) achieved a gross sales margin of 5.475 billion yuan in the first quarter, an increase of 117.09% over the same period last year.

Chizi City Technology (09911) expects social business revenue to increase by about 65% from 6.25 to 650 million yuan in the first quarter compared with the same period last year.

Chinalco International (02068) the newly signed contract value of 11.011 billion yuan in the first quarter increased by 50.32% over the same period last year.

Li Ning Co. Ltd. (02331): same-store sales in the first quarter grew by 20% per cent per year and 30 per cent year-on-year.

China Tower Corporation (00788) the profit attributable to shareholders in the first quarter was 2.18 billion yuan, up 28.7% from the same period last year.

Huadian International Power Co., Ltd. (01071) achieved a cumulative output of 56.08 million MW hours in the first quarter, down 10.62% from the same period last year.

Shandong Xinhua Pharmaceutical Co., Ltd. (00719) released first-quarter net profit of about 109 million yuan, an increase of 8.20% over the same period last year.

The revenue of Sunshine Energy (00757) in the first quarter was 1.107 billion yuan, an increase of 5.7% over the same period last year.

China Petroleum & Chemical Corp Refining and Chemical Engineering (02386) the total value of newly signed contracts in the first quarter was 31.37 billion yuan, an increase of 4.9% over the same period last year.

China Railway Construction Corporation (01186) newly signed contracts worth 465.9382 billion yuan in the first quarter, an increase of 1.53% over the same period last year.

Shandong Gold Mining (01787) released the return of the first quarter net profit of about 315 million yuan to profit compared with the same period last year.

China Taiping (00966): the original premium of Taiping Life Insurance was 56.174 billion yuan in the first quarter.

Fast Retailing (06288) medium-term profit attributable to shareholders 146.844 billion yen resumed trading on April 19th

The contract sales of Dayuecheng Real Estate (00207) in the first quarter is about 6.96 billion yuan.

Lenovo Holdings (03396) released its subsidiary Lianhong Xinke's first-quarter results, with operating income of 1.556 billion yuan.

Lenovo Holdings (03396) released the first-quarter results of affiliated Jiawo Foods, with a net profit of 110 million yuan compared with the same period last year.

East Ejiao hair Yingxi, affiliated to China Resources Pharmaceutical (03320), is expected to return to its mother with a net profit of 100 million yuan to 120 million yuan in the first quarter.

• Increase and decrease holdings

China Merchants Port (00144) accumulated 1.894 billion yuan to increase its stake in Shanghai Port Group to 28.06%.

• Repurchase cancellation

AIA Group Limited (01299) spent about HK $163 million to buy back 2.0808 million shares on April 19th.

Standard Chartered PLC (02888) 8.46 million pounds buyback 1.67 million shares on April 14

Kingsoft (03888) spent about HK $9.9674 million to buy back 433000 shares on April 19.

Ming Yuan Cloud Group (00909) spent about HK $9.3003 million to buy back 970000 shares on April 19.

• Additional placement

Hop King Pacific Group (01813) issues 1.0932 million shares under the share Award Scheme

Due to the ownership of restricted shares in Jiahe Bio-B (06998), 16250 shares were issued.

XPeng Inc.-W (09868) issued about 73750 shares under the 2019 equity incentive plan

• Equity incentive

Smoore International Holdings Limited (06969) awarded a total of 6.354 million award shares

Tradelink (00536) granted 7.4 million share options

Jinshan Software (03888) spent HK $9.967 million to buy back 433000 shares on April 19th.

Sai Sheng Pharmaceutical (06600) granted 18.046 million share options and a total of 2.41 million restricted shares

Straw Bear Entertainment (02125) granted a total of 3.859 million restricted shares

• Dividend dividend

Poly property (06049) plans to pay a final dividend of 0.305 yuan per share on August 5.

China Tongfu (01763) will pay a final dividend of 37.79 cents per share on July 23.